Næste

Automatisk afspilning

Kidney cancer: post-surgery sorafenib

0 Visninger • 06/26/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning